Ampio Pharmaceuticals

Home » Ampio Pharmaceuticals

Secondary

Ampio Pharmaceuticals

Pharmaceutical

Follow-On Offering: Our focus is on developing Ampion, which is a compound that decreases inflammation by inhibiting specific pro-inflammatory compounds.

Symbol

AMPE

Last Closing Price
$0.70

Shares
35,000,000

Anticipated Date
June 17, 2019

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

To view the prospectus for Ampio Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253